Clinical Trials on Moderate Pain

Total 24330 results

GlycoMimetics Incorporated

Completed

A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Moderate Hepatic Impairment | Normal Hepatic Function

United States
Helen Keller International
University of California, Davis; United Nations World Food Programme (WFP); U... and other collaborators

Completed

Management of Children With Moderate Acute Malnutrition in Mali (Mali-MMAM)

Moderate Acute Malnutrition (MAM)

Mali
Pfizer

Completed

Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction

Mild Hepatic Dysfunction | Moderate Hepatic Dysfunction

South Africa
Taisho Pharmaceutical Co., Ltd.

Completed

A Pharmacokinetic Study of TS-142 in Patients With Hepatic Impairment

Patients With Mild or Moderate Hepatic Impairment

Japan
Genesis Pharma S.A.
Celgene

Completed

A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study) (APRAISAL)

Moderate Plaque Psoriasis

Greece
University of Luebeck

Completed

Effectiveness of Internet-based Depression Treatment (EVIDENT)

Mild to Moderate Depressive Symptoms

Germany
AB Biotics, SA

Completed

A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia

Moderate Hypercholesterolemia

France
Brigham and Women's Hospital
GlaxoSmithKline

Unknown

Lovaza Mechanisms of Action

Moderate Hypertriglyceridemia.

United States
Mundipharma Research GmbH & Co KG

Completed

A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy

Moderate to Severe Pain Due to Diabetic Polyneuropathy

Germany
VA Office of Research and Development

Active, not recruiting

Neurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSD (EXCPPTSD)

Chronic Musculoskeletal Pain | Posttraumatic Stress Disorder (PTSD) | Mild or Moderate Traumatic Brain Injury

United States
Fujian Cancer Hospital

Withdrawn

Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

Cancer Pains
AbbVie

Recruiting

A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Moderate Plaque Psoriasis

United States, Puerto Rico, Canada, Australia
The University of Hong Kong

Suspended

Effectiveness of Online Group-based Nonviolent Communication Interventions

Mild to Moderate Depressive Symptoms

China
Postgraduate Institute of Dental Sciences Rohtak

Recruiting

COMPARATIVE EVALUATION OF DIRECT PULP CAPPING AND COMPLETE PULPOTOMY IN MATURE PERMANENT MANDIBULAR MOLARS WITH CLINICAL SIGNS INDICATIVE OF MODERATE PULPITIS

Moderate Pulpitis

India
Janssen Research & Development, LLC

Recruiting

Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis (SPECTREM)

Moderate Plaque Psoriasis

United States, Canada
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Study on Human Mass Balance of SPH3127 Tablets

Primary Mild and Moderate Hypertension

China
Lipidor AB

Recruiting

A Phase III Study in Subjects With Mild to Moderate Psoriasis. (AKVANO-AKP02)

Mild to Moderate Psoriasis

India
University of Tromso
Sorlandet Hospital HF

Not yet recruiting

The Impact of Spiritual Healing on Moderate Depression in Adults

Moderate Depression

Norway
Bioksan
Analysis and Research Network, S.L

Completed

Clinical Trial to Demonstrate the Efficacy of a Dietary Supplement in Decreasing Cardiovascular Risk

Low-Moderate Hypercholesterolemia

Spain
Actavis Inc.

Completed

Clinical Endpoint Study of Ivermectin 1% Cream

Moderate to Severe Papulopustular Rosacea

United States
Betta Pharmaceuticals Co., Ltd.
Tigermed Consulting Co., Ltd

Terminated

Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Mild to Moderate Psoriasis

China
BioMAS Ltd

Withdrawn

Topical Application of AS101 for the Treatment of Psoriasis

Mild to Moderate Psoriasis

Israel
Kristian Reich, MD
LEO Pharma

Completed

Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) (PSO-TOP)

Mild to Moderate Psoriasis

United Kingdom, Germany, France, Spain, Netherlands, Sweden, Italy, Denmark
Astellas Pharma Europe B.V.

Completed

A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects

Healthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic Impairment

Slovakia
Zimmer Biomet

Terminated

ROSA Total Knee Investigational Testing Authorization Study

Rheumatoid Arthritis | Knee Pain | Chronic Osteoarthritis | Moderate Varus, Valgus or Flexion Deformities | Avascular Necrosis of Femoral Condyle

Canada
Zimmer Biomet

Completed

ROSA Robot Used in Total Knee Replacement Post Market Study

Rheumatoid Arthritis | Knee Pain | Chronic Osteoarthritis | Avascular Necrosis of the Femoral Condyle | Moderate Varus, Valgus or Flexion Deformities

United States
Ethicon, Inc.

Recruiting

The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study

Controlling Mild to Moderate Bleeding During Surgery

United States, United Kingdom
The University of Tennessee, Knoxville

Active, not recruiting

Treating Depression With Text Messaging

Moderate Depression

United States
Edwards Lifesciences

Terminated

Hypotension Prediction Index (HPI) SMART-BP Trial

Moderate to High-risk Noncardiac Surgery

United States
Shanghai Junshi Bioscience Co., Ltd.

Completed

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

Moderate to Severe Psoriasis

China
Daiichi Sankyo, Inc.

Completed

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Moderate Hepatic Impairment

United States
Bristol-Myers Squibb

Terminated

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Psoriasis, Moderate to Severe

United States
Etwal Ltd.

Completed

Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis

Mild to Moderate Psoriasis

Israel
Action Against Hunger USA
University of Washington; Ethiopian Public Health Institute

Not yet recruiting

Family Mid-Upper Arm Circumference (MUAC) Follow-up After Recovery From Acute Malnutrition (MODAM-fMUAC) (MODAM-fMUAC)

Moderate Acute Malnutrition | Severe Acute Malnutrition
University Hospital, Toulouse

Recruiting

Paramedical Tele-education on Moderate Depressive Episodes (TE-DSP)

Depression | Depression Moderate

France
Pfizer

Recruiting

A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction

Healthy Volunteers | Moderate Hepatic Impairment | Severe Hepatic Impairment

United States
Bristol-Myers Squibb

Completed

A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Moderate Liver Impairment | Severe Liver Impairment

United States
Microbiome Health Research Institute
University of Cape Town

Terminated

Transfer of Healthy Gut Flora for Restoration of Intestinal Microbiota Via Enema for Patients in the Rehabilitative Phase of Malnutrition (THRIVE)

Moderate Acute Malnutrition | Severe Acute Malnutrition

South Africa
Wake Forest University Health Sciences

Completed

Biologics Anchoring Study

Moderate-to-severe Psoriasis

United States
Bristol-Myers Squibb
Nitto Denko Corporation

Completed

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)

Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)

Bulgaria, United States
Merck KGaA, Darmstadt, Germany

Completed

CLEAR Study: Clinical Experience Acquired With Raptiva Study

Moderate to Severe Psoriasis

Switzerland
Merck KGaA, Darmstadt, Germany

Completed

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

Moderate to Severe Psoriasis

Switzerland
UCB Celltech

Completed

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis

Mild to Moderate Psoriasis

United Kingdom
Pfizer

Completed

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Moderate to Severe Psoriasis

Korea, Republic of
GC Cell Corporation

Recruiting

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Moderate to Severe Plaque Psoriasis

Korea, Republic of
Sun Yat-sen University

Recruiting

Study of Surgical Treatment Versus Observation in Children With Moderate Intermittent Exotropia (SOMIX)

Moderate Intermittent Exotropia

China
UCB Biopharma SRL

Active, not recruiting

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis (BE CONNECTED)

Moderate to Severe Plaque Psoriasis

United States, Canada, Germany, Poland
Takeda
Nimbus Lakshmi, Inc.; Innovaderm Research Inc.

Completed

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

United States, Canada
Biocad

Completed

An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis (BCD-085-7)

Moderate to Severe Plaque Psoriasis

Russian Federation
Institut Pasteur
Institut Pasteur de Madagascar; Action Contre la Faim; Centre de Recherches Médicales... and other collaborators

Completed

Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old (MALINEA)

Moderate Acute Malnutrition

Central African Republic, Madagascar, Niger, Senegal

Clinical Trials on Moderate Pain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations